Anthony Sonnenberg Comment On Regulatory Notice 22-08
Anthony Sonnenberg
N/A
To whom it may concern:
With great concern, I have learned about the restrictions that are being considered by regulators on investors' rights to invest in certain public investments like leveraged and inverse products.
I have used leveraged products for almost 10 years to enhance my investment returns and use inverse products to protect my investments during downturns. I have outperformed the market by a large margin and using my strategies and am more than capable of understanding how these products work, how they can help me, and what their risks are. Nothing complex about it. Yes, they may be higher risk, but they actually help me to MITIGATE risk. Ironic? Not really, this is what many investors like me do. We shouldn't have to go through special testing just so I can buy these public investments and minimize my risk.
Moreover, I should not be denied access to these public investments. Aren't they public for a reason? Where would this end, if we start restricting investments like these? And if regulators are choosing for the public what public funds we can and cannot buy.
I highly encourage regulators involved to reconsider these restrictions that would harm myself and investors like me. Investing involves risk no matter what and it is up to the investor to educate themselves and accept a risk level they are comfortable with.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Anthony Sonnenberg Comment On Regulatory Notice 22-08
To whom it may concern:
With great concern, I have learned about the restrictions that are being considered by regulators on investors' rights to invest in certain public investments like leveraged and inverse products.
I have used leveraged products for almost 10 years to enhance my investment returns and use inverse products to protect my investments during downturns. I have outperformed the market by a large margin and using my strategies and am more than capable of understanding how these products work, how they can help me, and what their risks are. Nothing complex about it. Yes, they may be higher risk, but they actually help me to MITIGATE risk. Ironic? Not really, this is what many investors like me do. We shouldn't have to go through special testing just so I can buy these public investments and minimize my risk.
Moreover, I should not be denied access to these public investments. Aren't they public for a reason? Where would this end, if we start restricting investments like these? And if regulators are choosing for the public what public funds we can and cannot buy.
I highly encourage regulators involved to reconsider these restrictions that would harm myself and investors like me. Investing involves risk no matter what and it is up to the investor to educate themselves and accept a risk level they are comfortable with.